Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.

MLA

Clifford, Gary M., et al. “Immunodeficiency and the Risk of Cervical Intraepithelial Neoplasia 2/3 and Cervical Cancer: A Nested Case-Control Study in the Swiss HIV Cohort Study.” International Journal of Cancer, vol. 138, no. 7, Apr. 2016, pp. 1732–40. EBSCOhost, https://doi.org/10.1002/ijc.29913.

APA

Clifford, G. M., Franceschi, S., Keiser, O., Schöni-Affolter, F., Lise, M., Dehler, S., Levi, F., Mousavi, M., Bouchardy, C., Wolfensberger, A., Darling, K. E., Staehelin, C., Bertisch, B., Kuenzli, E., Bernasconi, E., Pawlita, M., & Egger, M. (2016). Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. International Journal of Cancer, 138(7), 1732–1740. https://doi.org/10.1002/ijc.29913

Chicago

Clifford, Gary M, Silvia Franceschi, Olivia Keiser, Franziska Schöni-Affolter, Mauro Lise, Silvia Dehler, Fabio Levi, et al. 2016. “Immunodeficiency and the Risk of Cervical Intraepithelial Neoplasia 2/3 and Cervical Cancer: A Nested Case-Control Study in the Swiss HIV Cohort Study.” International Journal of Cancer 138 (7): 1732–40. doi:10.1002/ijc.29913.